Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Top 3 Canadian Graphite Stocks of 2025

August 14, 2025

Crypto Market Recap: Bitcoin Price Stalls as Fed...

June 21, 2025

Upcoming Meeting Dates – November 10, 2025

November 10, 2025

OTC Markets Group Welcomes Empire Metals LTD to...

September 3, 2025

Brunswick Exploration Announces AGM Results

June 14, 2025

Gold Price Dips, Markets Stay Flat as Fed...

May 8, 2025

Cartier Starts Metallurgical Testwork Program at Cadillac

September 30, 2025

Locksley Resources LimitedReceives up to US$191M Potential Support...

November 3, 2025

Tech 5: Meta Plans Multi-Billion AI Bet, Apple...

June 17, 2025

How to Invest in Gene Stocks and ETFs

August 29, 2025